PROSIGNA Trademark
PROSIGNA is a USPTO trademark filed by VERACYTE, INC.. Status: Registered.
Prosecution Summary
Trademark Summary
The mark PROSIGNA is a standard character word mark covering diagnostic reagents and reagent kits for scientific or research use (class 001) and medical use (class 005) in the field of breast cancer. It is owned by Veracyte, Inc., a Delaware corporation based in South San Francisco, California, following assignment from original owner NanoString Technologies, Inc. The mark is registered on the Principal Register (reg. no. 4585174), active, and renewed as of October 22, 2024, with no active oppositions or legal proceedings.
Recent Activity
Filed November 1, 2012, published for opposition October 22, 2013, and registered August 12, 2014, after statement of use. Most recently renewed for ten years on October 22, 2024, following acceptance of
Trademark Facts
| Mark | PROSIGNA |
|---|---|
| Serial Number | 85769651 |
| Registration Number | 4585174 |
| Status | Registered |
| Filing Date | 2012-11-01 |
| Registration Date | 2014-08-12 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals) |
| Owner | VERACYTE, INC. |
| Attorney of Record | Rosaleen H. Chou |
| Prosecution Events | 60 |
| Latest Event | COAR on 2025-01-30 |
Goods & Services
diagnostic reagents for medical use in the field of [ cancer ] * breast [, ovarian, bladder, lung, pancreatic, or prostate] cancer *; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of [ cancer ] * breast [, ovarian, bladder, lung, pancreatic, or prostate] cancer *; diagnostic reagents for scientific or research use in the field of [ cancer ] * breast, [ ovarian, bladder, lung, pancreatic, or prostate] cancer *; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of [ cancer ] * breast [, ovarian, bladder, lung, pancreatic, or prostate ] cancer *